Sunshine Lake Pharma Co., Ltd.: all 86 studies

Page 1 of 1. Open to participants first (13), then studies with results posted, then the rest; newest registration first within each.

• HEC53856 Tablets for Chemotherapy-induced Anemia in Non-myeloid MalignanciesNot yet recruitingNCT07891377Phase 2
• HEC-921 Injection as Monotherapy and in Combination With Antineoplastic Therapies in Patients With Advanced Malignant Solid TumorsRecruitingNCT07824934Phase 1
• A Phase I Clinical Trial to Evaluate HECN30227 Injection in Healthy Subjects and Subjects With Chronic Hepatitis BRecruitingNCT07771140Phase 1
• Single-ascending Dose Study of HEC-151 InjectionRecruitingNCT07376200Phase 1
• A Single-center, Randomized, Open-label, Parallel-design Clinical Study to Evaluate the Pharmacokinetic Effects of Itraconazole, Fluconazole or Efavirenz on a Single Dose of Clifutinib in Healthy ParticipantsNot yet recruitingNCT07341672Phase 1
• A Study to Evaluate the Safety, Tolerability, PK/PD of HEC-007 Injection in Healthy and Overweight/Obese SubjectsRecruitingNCT07102251Phase 1
• A Safety, Tolerability, Pharmacokinetics/Pharmacodynamics Study of HEC169584 Capsules in Healthy SubjectsRecruitingNCT07099118Phase 1
• Confirmatory Clinical Study of HEC585 Tablets in Patients With IPFRecruitingNCT07082842Phase 3
• HEC73543 Versus Salvage Chemotherapy in R/R FLT3-ITD AMLRecruitingNCT05586074Phase 3
• A Study to Explore the Therapeutic Effect of HEC585 on Delaying Forced Vital Capacity (FVC) Decline and Tolerance in Progressive Fibrosing Interstitial Lung Disease (PF-ILD) PatientsRecruitingNCT05139719Phase 2
• A Phase Ⅰb/Ⅱ Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AMLRecruitingNCT05133882Phase 1/2
• The Efficacy And Safety Of Mitizodone Phosphate Tablets In The Treatment of Patient With Major Depressive DisorderRecruitingNCT04984512Phase 2/3
• Study of Larotinib in Unresectable Advanced or Recurrent Esophageal CancerRecruitingNCT04415853Phase 3
• Study To Investigate The Potential DDI Between HEC585 And Pirfenidone/Nintedanib In Healthy SubjectsCompletedNCT07588646Phase 1
• Clinical Study on the Mass Balance of ClifutinibCompletedNCT07211165Phase 1
• Phase 2 Study of HEC88473 Injection in Subjects With Type 2 Diabetes MellitusCompletedNCT06148649Phase 2
• ADME Study of [14C] Yiqibuvir in Healthy Male SubjectsCompletedNCT05998304Phase 1
• A Phase 1 Study of HEC88473 Injection in Healthy Subjects, Obese Subjects and T2DM SubjectsCompletedNCT05943886Phase 1
• A Study of Insulin Degludec/Insulin Aspart Biosimilar (22011) Compared With Insulin Degludec/Insulin Aspart(Ryzodeg) in Participants With Type 2 Diabetes in ChinaCompletedNCT05802862Phase 3
• A Clinical Study Comparing the Pharmacokinetics and Pharmacodynamic Characteristics of Insulin Degludec Injection (RD15003) and Insulin Degludec Injection (Tresiba®) in Healthy SubjectsCompletedNCT05576298Phase 1
• Pharmacokinetics of Midazolam When Co-administered With HEC74647 and HEC110114CompletedNCT05504876Phase 1
• Effects of Rifampicin and Probenecid On The Pharmacokinetic Profile Of Rongliflozin In Healthy SubjectsCompletedNCT05497674Phase 1
• Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC73077 in Healthy SubjectsCompletedNCT05492630Phase 1
• Study on the Body Mass Balance and Biotransformation of [14C]-HEC585CompletedNCT05468346Phase 1
• A Pharmacokinetic Study Comparing the 14028 Injection and TRULICITY® in Healthy Chinese SubjectsCompletedNCT05459285Phase 1
• Clifutinib Food Effect Study in Healthy SubjectsCompletedNCT05454098Phase 1
• HEC169096 in Participants With Advanced Solid TumorsTerminatedNCT05451602Phase 1/2
• ADME Study of [14C] Antaitavir Hasophate in Healthy Male SubjectsCompletedNCT05446233Phase 1
• A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Pyroglutamate Rongliflozin Capsules in Subjects With Mild and Moderate Liver DamageCompletedNCT05427682Phase 1
• A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of HEC96719 in Subjects With Non-Cirrhotic Non-Alcoholic SteatohepatitisCompletedNCT05397379Phase 2
• Antaitavir Hasophate Capsules Combined With Yiqibuvir Tablets in Treatment Adult Patients With Chronic Hepatitis CCompletedNCT05395416Phase 2/3
• Evaluation Freethiadine Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of StudyCompletedNCT05391360Phase 1
• To Evaluate Drug-drug Interactions Between HEC585 and Pirfenidone or Nintedanib in Healthy VolunteersCompletedNCT05383131Phase 1
• A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of Rongliflozin in Type 2 Diabetic Subjects With Renal ImpairmentCompletedNCT05374343Phase 1
• A Pharmacokinetic Study Comparing the Liraglutide Injection (RD12014) and Victoza® in Healthy Chinese SubjectsCompletedNCT05294536Phase 1
• A Clinical Trial of HEC93077 in Chinese Healthy Subjects and HUA Patients With Single or Multiple DosingCompletedNCT05127772Phase 1
• ADME Study of [14C]- Rongliflozin in Healthy Male SubjectsCompletedNCT05109078Phase 1
• Phase ll Study of HEC585 in Patients With IPFActive, not recruitingNCT05060822Phase 2
• ADME Study of [14C]- Larotinib in Healthy Male SubjectsCompletedNCT05059743Phase 1
• A Study to Evaluate Drug-Drug Interaction of Larotinib With Itraconazole and Rifampin in Healthy Adult ParticipantsCompletedNCT05057949Phase 1
• Pharmacokinetics Study of Larotinib in Subjects With Impaired Hepatic FunctionWithdrawnNCT05048368Phase 1
• Ningetinib in Advanced NSCLC Skipping Mutations With MET Exon 14 Skipping MutationsWithdrawnNCT04992858Phase 2
• Single Dose and Multiple Dose Safety, Tolerability, PK，and Food Effect Study，and Interaction With Oseltamivir Study of HEC116094 in Healthy Adult SubjectsCompletedNCT04982913Phase 1
• Study of HEC53856 in Patients With Subjects With End-Stage Renal Disease Receiving Dialysis.CompletedNCT04925674Phase 1
• HEC53856 Phase Ib Study in Patients With Non-dialysis Renal AnemiaCompletedNCT04925661Phase 1
• A Study to Evaluate the Tolerability, Safety, Pharmacokinetics of HEC89736 in Patients With Relapsed or Refractory B-cell Hematologic MalignanciesTerminatedNCT04865458Phase 1
• The Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of HEC88473 in Healthy SubjectsCompletedNCT04829123Phase 1
• A Clinical Trial to Evaluate Clifutinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia(AML)CompletedNCT04827069Phase 1
• the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC83518 TabletsCompletedNCT04667429Phase 1
• Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC122505MsOH Tablets in Healthy Adult SubjectsCompletedNCT04625361Phase 1
• the Safety, Tolerability, and Pharmacokinetics Study of HEC113995CompletedNCT04623814Phase 1
• The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC83518 Tablets in Chinses Healthy SubjectsCompletedNCT04596007Phase 1
• The Safety, Tolerability, and Pharmacokinetics Study of HEC113995 PA•H2O Tablets in Healthy SubjectsCompletedNCT04591301Phase 1
• First-In-Human Phase I Trial of Ningetinib ( CT053PTSA ) in the Patients With Advanced Solid TumorsCompletedNCT04577703Phase 1
• Pharmacokinetics of Yimitasvir Phosphate Capsule in Subjects With Normal Renal Function and ESRDCompletedNCT04565171Phase 1
• To Evaluate the Pharmacokinetics and Safety of Yimitasvir Phosphate Capsules in Subjects With Moderate and Severe Liver Function Impairment and in Healthy SubjectsCompletedNCT04552808Phase 1
• GLS4/RTV and TAF Drug-drug InteractionCompletedNCT04551261Phase 1
• Multiple Dose Safety, Tolerability, PK，PD and Food Effect Study of HEC96719 in Healthy Adult SubjectsCompletedNCT04546984Phase 1
• Evaluation HEC121120 Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of StudyTerminatedNCT04536532Phase 1/2
• Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC585 in Healthy Male and Female SubjectsCompletedNCT04512170Phase 1
• The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy SubjectsCompletedNCT04422496Phase 1
• Clinical Study of HEC68498 in Patients With Advanced Refractory Solid TumorsCompletedNCT04324372Phase 1
• Drug-drug Interaction Study Between HEC74647PA Capsule and HEC110114 Tablets in Healthy SubjectsCompletedNCT04232514Phase 1
• The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC110114 Tablets in HCV-infected SubjectsCompletedNCT04202952Phase 1/2
• The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC74647 in HCV-infected SubjectsCompletedNCT04201275Phase 1
• The Tolerability , Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Adult SubjectsCompletedNCT04194242Phase 1
• Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV InfectionCompletedNCT04147208Phase 2
• Gemcitabine and Z650 in Treating Patients With Metastatic or Recurrent Pancreatic CancerTerminatedNCT04131192Phase 1
• The Study of a Selective Serotonin Partial Agonist and Reuptake Inhibitors, HEC113995PA•H2O,in Healthy SubjectsCompletedNCT03943251Phase 1
• The Tolerability and Pharmacokinetics Study of HEC110114 Tablets in Healthy Adult SubjectsCompletedNCT03903081Phase 1
• Z650 in Advanced Esophageal Squamous Cell Carcinoma With EGFR Over Expression or Gene AmplificationCompletedNCT03888092Phase 1/2
• HEC53856 Phase 1 Study - Single and Multiple Oral Dosing in Healthy VolunteersCompletedNCT03886688Phase 1
• A Single Arm, Open-label,Phase Ib Study of CT053PTSA in Preciously Treated Patients With Advanced and Metastatic RCCTerminatedNCT03876925Phase 1/2
• The Tolerability and Pharmacokinetics Study of Kangdaprevir Sodium Tablet in Healthy Adult SubjectsCompletedNCT03811678Phase 1
• Ningetinib (CT053PTSA) Plus Gefitinib in Stage IIIB or IV NSCLC Patients With EGFR Mutation and T790M NegativeCompletedNCT03758287Phase 1/2
• The Tolerability and Pharmacokinetics Study of HEC74647PA Capsule in Healthy Adult SubjectsCompletedNCT03673696Phase 1
• The Safety, Tolerability and Pharmacokinetic Study of Litapiprant Tablets in Healthy Male and Female SubjectsCompletedNCT03663686Phase 1
• A Drug-drug Interaction (DDI) Study of Morphothiadine Mesilate/Ritonavir in Healthy SubjectsCompletedNCT03662568Phase 1
• The Study of a Selective 5-ht6 Receptor Antagonist, HEC30654AcOH,in Healthy SubjectsCompletedNCT03655873Phase 1
• The Safety, Antiviral Activity, and Pharmacokinetics of Morphothiadine Mesilate CapsulesCompletedNCT03638076Phase 2
• The Safety, Tolerability and Pharmacokinetic Study of HEC68498 in Healthy Male and Female SubjectsCompletedNCT03502902Phase 1
• Phase 3 Study of Yimitasvir Phosphate CapsulesCompletedNCT03487107Phase 3
• The Safety, Tolerability and Pharmacokinetic Study of Yimitasvir in Healthy Adults SubjectsCompletedNCT03462173Phase 1
• Phase 2 Study of Yimitasvir Phosphate CapsulesCompletedNCT03458481Phase 2
• A Phase Ib Study of CT053PTSA in Relapsed / Refractory Acute Myeloid Leukemia (AML)TerminatedNCT03125876Phase 1
• The Safety, Tolerability and Pharmacokinetic Study of HEC585 in Healthy Male and Female SubjectsCompletedNCT03092102Phase 1

← Sunshine Lake Pharma Co., Ltd. overview and focus areas